Apjohn Ventures


Apjohn Ventures is a venture capital firm based in Kalamazoo, Michigan, focused on investing in early-stage life sciences companies across the Midwest. The firm aims to provide superior financial returns by investing in innovative life sciences companies with sustainable growth potential. Apjohn Ventures leverages its deep expertise in the pharmaceutical and biotech industries, extensive networks, and strategic perspectives to support the growth and success of its portfolio companies.

Apjohn Ventures

Apjohn Ventures

350 E. Michigan Avenue, Suite 500, Kalamazoo, MI 49007


What We Do

Apjohn Ventures provides strategic perspectives on business decisions that drive company value, leveraging their depth of pharmaceutical and biotech industry expertise.

The firm offers a breadth of networks to bring the right resources, people, and relationships to its portfolio companies.

Apjohn Ventures provides operational and financing experience with life sciences companies at all stages of development.

The firm has M&A and IPO backgrounds to facilitate successful exits at the right times.


Industry Focus


Portfolio

Acquired by Angiotech in October 2005.

#Drug Coated Device

Operates one of the world's largest human tissue banks.

#Human Tissue Bank

Focused on severe inflammatory disease associated with renal and cardio failures.

#Medical Device

Acquired by Upsher-Smith in June 2010.

#Specialty Pharmaceutical

Develops targeted therapeutics and molecular imaging agents for cancer and cardiovascular disease.

#Biotechnology

Leverages nucleic acid-based interfering technology, DNAi, for cancer therapies.

#Biotechnology


Key People

Founder and General Partner

Founder and General Partner

Controller

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.